Skip to main content

Patient Compliance

3
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
Ibuprofen 400 mg capletPhase 31 trial
Active Trials
NCT02294019Completed738Est. May 2015
MSD
MSDIreland - Ballydine
1 program
1
Electronic MessagePhase 11 trial
Active Trials
NCT01568515Completed283Est. Aug 2014
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
Electronic MessagePhase 1
ResMed
ResMedSAN DIEGO, CA
1 program
Automatic Positive Airway PressureN/A1 trial
Active Trials
NCT02339597Unknown224Est. Nov 2015
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
virtual reality videosN/A1 trial
Active Trials
NCT03667911Unknown322Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerIbuprofen 400 mg caplet
MSDElectronic Message
UNION therapeuticsvirtual reality videos
ResMedAutomatic Positive Airway Pressure

Clinical Trials (4)

Total enrollment: 1,567 patients across 4 trials

NCT02294019PfizerIbuprofen 400 mg caplet

Actual Use Trial of Ibuprofen 400 mg

Start: Nov 2014Est. completion: May 2015738 patients
Phase 3Completed
NCT01568515MSDElectronic Message

Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students

Start: Oct 2011Est. completion: Aug 2014283 patients
Phase 1Completed
NCT03667911UNION therapeuticsvirtual reality videos

Virtual Reality Videos in Improving Bowel Preparation Quality of Colonoscopy

Start: Sep 2018Est. completion: Dec 2019322 patients
N/AUnknown
NCT02339597ResMedAutomatic Positive Airway Pressure

Therapy Adherence of APAP Therapy Initiation in Sleep-lab Versus at Home

Start: Jan 2014Est. completion: Nov 2015224 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.